These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 10644927

  • 1. Age-sensitive cognitive function, growth hormone and insulin-like growth factor 1 plasma levels in healthy older men.
    Aleman A, de Vries WR, de Haan EH, Verhaar HJ, Samson MM, Koppeschaar HP.
    Neuropsychobiology; 2000 Jan; 41(2):73-8. PubMed ID: 10644927
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor-I and cognitive function in healthy older men.
    Aleman A, Verhaar HJ, De Haan EH, De Vries WR, Samson MM, Drent ML, Van der Veen EA, Koppeschaar HP.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):471-5. PubMed ID: 10022403
    [Abstract] [Full Text] [Related]

  • 3. Relationship between cognitive function, growth hormone and insulin-like growth factor I plasma levels in aged subjects.
    Rollero A, Murialdo G, Fonzi S, Garrone S, Gianelli MV, Gazzerro E, Barreca A, Polleri A.
    Neuropsychobiology; 1998 Feb; 38(2):73-9. PubMed ID: 9732206
    [Abstract] [Full Text] [Related]

  • 4. The insulin-like growth factor axis and plasma lipid levels in the elderly.
    Ceda GP, Dall'Aglio E, Magnacavallo A, Vargas N, Fontana V, Maggio M, Valenti G, Lee PD, Hintz RL, Hoffman AR.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):499-502. PubMed ID: 9467564
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A, Kaufman JM, Giagulli VA.
    J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
    Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR.
    J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
    [Abstract] [Full Text] [Related]

  • 11. Does growth hormone prevent aging in the healthy elderly with low serum insulin-like growth factor-I ?
    Lee KO, Liao L, Mukherjee JJ.
    Mech Ageing Dev; 2004 Apr; 125(4):291-5. PubMed ID: 15063105
    [Abstract] [Full Text] [Related]

  • 12. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O, Laughlin GA, Yen SS.
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [Abstract] [Full Text] [Related]

  • 13. Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback.
    Chapman IM, Hartman ML, Pezzoli SS, Harrell FE, Hintz RL, Alberti KG, Thorner MO.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2996-3004. PubMed ID: 9284733
    [Abstract] [Full Text] [Related]

  • 14. Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition.
    Vahl N, Møller N, Lauritzen T, Christiansen JS, Jørgensen JO.
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3612-8. PubMed ID: 9360515
    [Abstract] [Full Text] [Related]

  • 15. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA, Maki KC, Unterman TG.
    J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
    [Abstract] [Full Text] [Related]

  • 16. Aging and the growth hormone/insulin like growth factor-I axis.
    Sherlock M, Toogood AA.
    Pituitary; 2007 May; 10(2):189-203. PubMed ID: 17492509
    [Abstract] [Full Text] [Related]

  • 17. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
    Bowers CY, Granda R, Mohan S, Kuipers J, Baylink D, Veldhuis JD.
    J Clin Endocrinol Metab; 2004 May; 89(5):2290-300. PubMed ID: 15126555
    [Abstract] [Full Text] [Related]

  • 18. Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis.
    Frutos MG, Cacicedo L, Fernández C, Vicent D, Velasco B, Zapatero H, Sánchez-Franco F.
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1140-52. PubMed ID: 17684105
    [Abstract] [Full Text] [Related]

  • 19. Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults.
    Chapman IM, Pescovitz OH, Murphy G, Treep T, Cerchio KA, Krupa D, Gertz B, Polvino WJ, Skiles EH, Pezzoli SS, Thorner MO.
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3455-63. PubMed ID: 9329386
    [Abstract] [Full Text] [Related]

  • 20. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency.
    Juul A, Holm K, Kastrup KW, Pedersen SA, Michaelsen KF, Scheike T, Rasmussen S, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2497-502. PubMed ID: 9253324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.